Search Results - Ibrahim C. Haznedaroglu

Refine Results
  1. 1

    DRUG THERAPY IN THE PROGRESSED CML PATIENT WITH MULTI-TKI FAILURE by Ibrahim C. Haznedaroglu

    Get full text
    Article


  2. 2

    Immunogenomic phases of COVID-19 and appropriate clinical management by Ibrahim C Haznedaroglu

    Published in The Lancet Microbe (2020-11-01)
    Get full text
    Article


  3. 3

    Monitoring the response to tyrosine kinase inhibitor (TKI) treatment in chronic myeloid leukemia (CML) by Ibrahim C. Haznedaroglu

    Get full text
    Article


  4. 4

    MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML) by Ibrahim C. Haznedaroglu

    Get full text
    Article


  5. 5

    Current Management of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors by İbrahim C. Haznedaroğlu

    Published in Turkish Journal of Hematology (2013-09-01)
    Get full text
    Article


  6. 6

    COVID-19, Renin-Angiotensin System, and Hematopoiesis by Rafiye Çiftçiler, İbrahim C. Haznedaroğlu

    Published in Turkish Journal of Hematology (2020-08-01)
    Get full text
    Article


  7. 7

    On Being a 'Physician Patient' with His Own Experimental Therapeutic Drug by Rafiye Çiftçiler, İbrahim C. Haznedaroğlu

    Published in Turkish Journal of Hematology (2018-11-01)
    Get full text
    Article


  8. 8

    Tumor Lysis Syndrome Due to Targeting of Hepatocellular Carcinoma Associated with Chronic Myelomonocytic Leukemia by Müfide Okay, Sıla Çetik, İbrahim C. Haznedaroğlu

    Published in Turkish Journal of Hematology (2019-08-01)
    Get full text
    Article


  9. 9

    WHO 2016 Definition of Chronic Myeloid Leukemia and Tyrosine Kinase Inhibitors by İbrahim C. Haznedaroğlu, Işınsu Kuzu, Osman İlhan

    Published in Turkish Journal of Hematology (2020-02-01)
    Get full text
    Article


  10. 10

    Antibacterial Activities of Ankaferd Hemostat (ABS) on Shiga Toxin-Producing Escherichia coli and Other Pathogens Significant in Foodborne Diseases by Ahmet Koluman, Nejat Akar, İbrahim C. Haznedaroğlu

    Published in Turkish Journal of Hematology (2017-03-01)
    Get full text
    Article


  11. 11

    Functional proteomic analysis of Ankaferd® Blood Stopper by Duygu Özel Demiralp, İbrahim C. Haznedaroglu, Nejat Akar

    Published in Turkish Journal of Hematology (2010-06-01)
    Get full text
    Article


  12. 12

    Functional proteomic analysis of Ankaferd® Blood Stopper by Duygu Özel Demiralp, İbrahim C. Haznedaroğlu, Nejat Akar

    Published in Turkish Journal of Hematology (2010-06-01)
    Get full text
    Article


  13. 13

    Retrospective evaluation of chromosome 1 anomalies in hematologic malignancies: A single center study by Süreyya Bozkurt, Müfide Okay, Filiz Sağlam, İbrahim C Haznedaroğlu

    Published in Genetics & Applications (2019-12-01)
    Get full text
    Article


  14. 14

    Nilotinib-Associated Multiple Silent Arterial Stenoses in a Patient with Chronic Myeloid Leukemia by Mert Tokatlı, Rashad Ismayilov, Olgu Erkin Çınar, İbrahim C. Haznedaroğlu

    Published in Turkish Journal of Hematology (2024-03-01)
    Get full text
    Article


  15. 15

    Local Bone Marrow Renin-Angiotensin System and Atherosclerosis by Yavuz Beyazit, Tugrul Purnak, Gulay Sain Guven, Ibrahim C. Haznedaroglu

    Published in Cardiology Research and Practice (2011-01-01)
    Get full text
    Article


  16. 16

    In vivo confocal microscopic characteristics of crystalline keratopathy in patients with monoclonal gammopathy: Report of two cases by Sibel Kocabeyoglu, Mehmet C Mocan, Ibrahim C Haznedaroglu, Aysegul Uner, Enes Uzunosmanoglu, Murat Irkec

    Published in Indian Journal of Ophthalmology (2014-01-01)
    Get full text
    Article


  17. 17

    The Impact of Eltrombopag Administration on the Clinical Course of Severe Refractory Fatal Acquired Aplastic Anemia by Ayşe Işık, Eylem Eliaçık, İbrahim C. Haznedaroğlu, Salih Aksu, Nilgün Sayınalp, Yahya Büyükaşık, Hakan Göker, Osman Özcebe

    Published in Turkish Journal of Hematology (2013-09-01)
    Get full text
    Article


  18. 18

    Surgical and histopathological effects of topical Ankaferd hemostat on major arterial vessel injury related to elevated intra-arterial blood pressure by A. Tulga Ulus, Nilüfer N. Turan, Sertan Özyalçın, Gülden Aydoğ, Fatma Ulus, Hakan Göker, İbrahim C. Haznedaroğlu

    Published in Turkish Journal of Hematology (2011-09-01)
    Get full text
    Article


  19. 19

    Comparison of bortezomib-cyclophosphamide-dexamethasone <em>versus</em> bortezomib-dexamethasone based regimens in newly diagnosed multiple myeloma patients by Rafiye Ciftciler, Hakan Goker, Yahya Buyukasik, Nilgun Sayınalp, Ibrahim C. Haznedaroglu, Salih Aksu, Osman Ozcebe, Haluk Demiroglu

    Published in Hematology Reports (2020-05-01)
    Get full text
    Article


  20. 20

    Surgical and histopathological effects of topical Ankaferd® hemostat on major arterial vessel injury related to elevated intra-arterial blood pressure by Tulga A. Ulus, Nilüfer N. Turan, Sertan Özyalçın, Gülden Aydoğ, Fatma Ulus, Hakan Göker, İbrahim C. Haznedaroğlu

    Published in Turkish Journal of Hematology (2011-08-01)
    Get full text
    Article


Search Tools: